CL
Clearside Bio
CLSD·NASDAQAlpharetta GAFounded 201120 employees
Micro CapbiotechPublicOphthalmology
Platform: SCS Microinj
Market Cap
$0.05B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (CLSD)
Loading CLSD stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxatenlimab | CLS-1095 | Phase 3 | 1 | MALT1 | Parkinson'sMG | ||
| CLS-4466 | CLS-4466 | NDA/BLA | 2 | CD20 | RA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)